• SPX
  • $5,738.17
  • -0.13 %
  • -$7.20
  • DJI
  • $42,313.00
  • 0.33 %
  • $137.89
  • N225
  • $39,829.56
  • 2.32 %
  • $903.93
  • FTSE
  • $8,320.76
  • 0.43 %
  • $35.85
  • IXIC
  • $18,119.59
  • -0.39 %
  • -$70.70

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

By Reuters   |   Apr 25, 2024 at 09:39 AM EST
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

By Blake Brittain

(Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.

(Reporting by Blake Brittain)

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.